Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Muratori

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Gut|March 15, 2000
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membraneL Muratori, M Parola, A Ripalti, et al.
Clinical and Experimental Immunology|January 10, 2003
Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general populationP Muratori, L Muratori, T Stroffolini, et al.
Clinical and Experimental Immunology|December 18, 2003
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?P Muratori, L Muratori, M E Gershwin, et al.
International Journal of Immunopathology and Pharmacology|March 6, 2004
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51D-P Bogdanos, M Lenzi, M Okamoto, et al.
Alimentary Pharmacology & Therapeutics|January 9, 2007
Antinuclear antibodies giving the 'multiple nuclear dots' or the 'rim-like/membranous' patterns: diagnostic accuracy for primary biliary cirrhosisA Granito, P Muratori, L Muratori, et al.
Alimentary Pharmacology & Therapeutics|September 5, 2007
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosisA Granito, P Muratori, L Muratori, et al.
Journal of Viral Hepatitis|December 16, 2016
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and olderF Conti, S Brillanti, F Buonfiglioli, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Gut|March 15, 2000
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membraneL Muratori, M Parola, A Ripalti, et al.
Clinical and Experimental Immunology|January 10, 2003
Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general populationP Muratori, L Muratori, T Stroffolini, et al.
Clinical and Experimental Immunology|December 18, 2003
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?P Muratori, L Muratori, M E Gershwin, et al.
International Journal of Immunopathology and Pharmacology|March 6, 2004
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51D-P Bogdanos, M Lenzi, M Okamoto, et al.
Alimentary Pharmacology & Therapeutics|January 9, 2007
Antinuclear antibodies giving the 'multiple nuclear dots' or the 'rim-like/membranous' patterns: diagnostic accuracy for primary biliary cirrhosisA Granito, P Muratori, L Muratori, et al.
Alimentary Pharmacology & Therapeutics|September 5, 2007
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosisA Granito, P Muratori, L Muratori, et al.
Journal of Viral Hepatitis|December 16, 2016
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and olderF Conti, S Brillanti, F Buonfiglioli, et al.
Pageof 3